Indeed, TH and its analogs, such as resmetirom (MGL-3196), eprotirome, and sobetirome, prove to be effective in treating liver steatosis in preclinical models and patients with NAFLD (23–25). This evidence concerns the gene TH and metabolic dysfunction-associated steatotic liver disease.